ACC.26 advanced registration ends Feb. 12 – register now!

Emily Claire O'Brien, PhD

Emily O'Brien

General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: Pfizer(SIGNIFICANT)

View Full Disclosure